Background Non–pharmaceutical interventions (NPIs) have been criticized as ineffective in preventing COVID. Because it is a new disease with NPIs introduced almost immediately, we have no way to easily and directly evaluate the counterfactual of non–intervention. We do, however, have excellent historic data on influenza, a respiratory disease with similar patterns of transmission and a well–established CDC surveillance system in the US. These data provide us an excellent way to indirectly evaluate the efficacy of these interventions and factors influencing that efficacy. Results During the three seasons prior to COVID from 2016–17 to 2018–19, the mean total US influenza mortality was 9,917 deaths per season. During the pandemic, influenza mortality was reduced by 91 percent in the 2020–21 and 69 percent in the 2021–22 influenza seasons relative to historical levels. The corresponding decreases for the pediatric population were 99 percent and 67 percent. At the state level, the average drop in mortality over the two flu seasons of the pandemic was strongly correlated with the percent of the 2020 presidential votes cast for Joe Biden in each state. Conclusions These data provide strong evidence that COVID NPIs dramatically reduced the spread of influenza. Given its similar routes of transmission, these results support the assertion that these interventions also substantially reduced COVID transmission, morbidity, and mortality. The effectiveness of NPIs increased in proportion to the size of the Democratic electorate in each state. This could reflect more effective NPI strategies in states with Democratic leanings or better compliance with NPIs in those states.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data are publicly available through existing websites.